Thomas R. Kozel - Publications

Affiliations: 
Cell and Molecular Biology University of Nevada, Reno, Reno, NV, United States 
Area:
Microbiology Biology, Immunology

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Burnham-Marusich AR, Zayac KR, Galgiani JN, Lewis L, Kozel TR. Antigenic Relatedness between Mannans from and Spherules and Mycelia. Journal of Fungi (Basel, Switzerland). 10. PMID 38392761 DOI: 10.3390/jof10020089  0.34
2020 Burnham-Marusich AR, Olsen RK, Scarbrough J, Kvam A, Yang W, Zimmerman L, Dunn JJ, Merkel T, Kozel TR. Tracheal colonization factor A (TcfA) is a biomarker for rapid and specific detection of Bordetella pertussis. Scientific Reports. 10: 15002. PMID 32929160 DOI: 10.1038/S41598-020-72092-6  0.426
2019 Kolton CB, Marston CK, Stoddard RA, Cossaboom C, Salzer JS, Kozel TR, Gates-Hollingsworth MA, Cleveland CA, Thompson AT, Dalton MF, Yabsley MJ, Hoffmaster AR. Detection of Bacillus anthracis in Animal Tissues using InBios Active Anthrax Detect Rapid Test Lateral Flow Immunoassay. Letters in Applied Microbiology. PMID 30776143 DOI: 10.1111/Lam.13134  0.309
2018 Burnham-Marusich AR, Hubbard B, Kvam AJ, Gates-Hollingsworth M, Green HR, Soukup E, Limper AH, Kozel TR. Conservation of Mannan Synthesis in Fungi of the Zygomycota and Ascomycota Reveals a Broad Diagnostic Target. Msphere. 3. PMID 29720523 DOI: 10.1128/mSphere.00094-18  0.693
2015 Nishiya CT, Boxx GM, Robison K, Itatani C, Kozel TR, Zhang MX. Influence of IgG subclass on human antimannan antibody-mediated resistance to hematogenously disseminated candidiasis in mice. Infection and Immunity. PMID 26573736 DOI: 10.1128/Iai.00890-15  0.397
2015 Gates-Hollingsworth MA, Perry MR, Chen H, Needham J, Houghton RL, Raychaudhuri S, Hubbard MA, Kozel TR. Immunoassay for Capsular Antigen of Bacillus anthracis Enables Rapid Diagnosis in a Rabbit Model of Inhalational Anthrax. Plos One. 10: e0126304. PMID 25942409 DOI: 10.1371/Journal.Pone.0126304  0.677
2015 Davis MJ, Eastman AJ, Qiu Y, Gregorka B, Kozel TR, Osterholzer JJ, Curtis JL, Swanson JA, Olszewski MA. Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence. Journal of Immunology (Baltimore, Md. : 1950). 194: 2219-31. PMID 25637026 DOI: 10.4049/Jimmunol.1402376  0.326
2015 Gates-Hollingsworth MA, Perry MR, Chen H, Needham J, Houghton RL, Raychaudhuri S, Hubbard MA, Kozel TR. Sensitivity of LFA for detection of purified poly-γ-D-glutamic acid (PGA) in pooled normal rabbit plasma and human serum. Plos One. DOI: 10.1371/Journal.Pone.0126304.G002  0.661
2014 Kozel TR. The road to toxin-targeted therapeutic antibodies. Mbio. 5: e01477-14. PMID 25006234 DOI: 10.1128/Mbio.01477-14  0.462
2013 Chaves SJ, Schegg K, Kozel TR, Aucoin DP. In Vivo Microbial Antigen Discovery (InMAD) to identify diagnostic proteins and polysaccharides that are circulating during microbial infections. Methods in Molecular Biology (Clifton, N.J.). 1061: 155-65. PMID 23963936 DOI: 10.1007/978-1-62703-589-7_9  0.738
2013 Hubbard MA, Thorkildson P, Kozel TR, AuCoin DP. Constant domains influence binding of mouse-human chimeric antibodies to the capsular polypeptide of Bacillus anthracis. Virulence. 4: 483-8. PMID 23863605 DOI: 10.4161/Viru.25711  0.703
2013 Hovenden M, Hubbard MA, Aucoin DP, Thorkildson P, Reed DE, Welch WH, Lyons CR, Lovchik JA, Kozel TR. IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis. Plos Pathogens. 9: e1003306. PMID 23637599 DOI: 10.1371/Journal.Ppat.1003306  0.696
2013 Hubbard MA, Thorkildson P, Welch WH, Kozel TR. Stereo-selective binding of monoclonal antibodies to the poly-γ-D-glutamic acid capsular antigen of Bacillus anthracis. Molecular Immunology. 55: 337-44. PMID 23602451 DOI: 10.1016/J.Molimm.2013.03.010  0.709
2013 Gates-Hollingsworth MA, Kozel TR. Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen. Clinical and Vaccine Immunology : Cvi. 20: 634-5. PMID 23365202 DOI: 10.1128/Cvi.00732-12  0.372
2013 Hansen J, Slechta ES, Gates-Hollingsworth MA, Neary B, Barker AP, Bauman S, Kozel TR, Hanson KE. Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clinical and Vaccine Immunology : Cvi. 20: 52-5. PMID 23114703 DOI: 10.1128/Cvi.00536-12  0.391
2012 Griffiths EJ, Hu G, Fries B, Caza M, Wang J, Gsponer J, Gates-Hollingsworth MA, Kozel TR, De Repentigny L, Kronstad JW. A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans. Molecular Microbiology. 86: 1404-23. PMID 23078142 DOI: 10.1111/Mmi.12065  0.323
2012 AuCoin DP, Reed DE, Marlenee NL, Bowen RA, Thorkildson P, Judy BM, Torres AG, Kozel TR. Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei. Plos One. 7: e35386. PMID 22530013 DOI: 10.1371/Journal.Pone.0035386  0.401
2011 Jarvis JN, Percival A, Bauman S, Pelfrey J, Meintjes G, Williams GN, Longley N, Harrison TS, Kozel TR. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 1019-23. PMID 21940419 DOI: 10.1093/Cid/Cir613  0.359
2011 Nuti DE, Crump RB, Dwi Handayani F, Chantratita N, Peacock SJ, Bowen R, Felgner PL, Davies DH, Wu T, Lyons CR, Brett PJ, Burtnick MN, Kozel TR, AuCoin DP. Identification of circulating bacterial antigens by in vivo microbial antigen discovery. Mbio. 2. PMID 21846829 DOI: 10.1128/Mbio.00136-11  0.492
2011 Percival A, Thorkildson P, Kozel TR. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen. Clinical and Vaccine Immunology : Cvi. 18: 1292-6. PMID 21697342 DOI: 10.1128/Cvi.05052-11  0.482
2011 Piccioni M, Monari C, Bevilacqua S, Perito S, Bistoni F, Kozel TR, Vecchiarelli A. A critical role for FcgammaRIIB in up-regulation of Fas ligand induced by a microbial polysaccharide Clinical and Experimental Immunology. 165: 190-201. PMID 21605112 DOI: 10.1111/J.1365-2249.2011.04415.X  0.317
2010 Boxx GM, Kozel TR, Nishiya CT, Zhang MX. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans. Infection and Immunity. 78: 1250-9. PMID 20028806 DOI: 10.1128/Iai.00744-09  0.436
2010 AuCoin DP, Crump RB, Thorkildson P, Nuti DE, LiPuma JJ, Kozel TR. Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody. Journal of Medical Microbiology. 59: 41-7. PMID 19729457 DOI: 10.1099/Jmm.0.012500-0  0.365
2009 Gates-Hollingsworth MA, Kozel TR. Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule. Molecular Microbiology. 74: 126-38. PMID 19758241 DOI: 10.1111/J.1365-2958.2009.06855.X  0.366
2009 Boyer AE, Quinn CP, Hoffmaster AR, Kozel TR, Saile E, Marston CK, Percival A, Plikaytis BD, Woolfitt AR, Gallegos M, Sabourin P, McWilliams LG, Pirkle JL, Barr JR. Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques Infection and Immunity. 77: 3432-3441. PMID 19506008 DOI: 10.1128/Iai.00346-09  0.307
2009 AuCoin DP, Sutherland MD, Percival AL, Lyons CR, Lovchik JA, Kozel TR. Rapid detection of the poly-gamma-D-glutamic acid capsular antigen of Bacillus anthracis by latex agglutination. Diagnostic Microbiology and Infectious Disease. 64: 229-32. PMID 19345041 DOI: 10.1016/J.Diagmicrobio.2009.02.001  0.676
2009 Botts MR, Giles SS, Gates MA, Kozel TR, Hull CM. Isolation and characterization of Cryptococcus neoformans spores reveal a critical role for capsule biosynthesis genes in spore biogenesis. Eukaryotic Cell. 8: 595-605. PMID 19181873 DOI: 10.1128/Ec.00352-08  0.366
2009 Tian H, Weber S, Thorkildson P, Kozel TR, Pirofski LA. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice. Infection and Immunity. 77: 1502-13. PMID 19168739 DOI: 10.1128/Iai.01075-08  0.348
2009 Boxx GM, Nishiya CT, Kozel TR, Zhang MX. Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans. Molecular Immunology. 46: 473-80. PMID 19038459 DOI: 10.1016/J.Molimm.2008.10.008  0.407
2009 Sutherland MD, Kozel TR. Macrophage uptake, intracellular localization, and degradation of poly-gamma-D-glutamic acid, the capsular antigen of Bacillus anthracis. Infection and Immunity. 77: 532-8. PMID 19001075 DOI: 10.1128/Iai.01009-08  0.666
2008 Sutherland MD, Thorkildson P, Parks SD, Kozel TR. In vivo fate and distribution of poly-gamma-D-glutamic acid, the capsular antigen from Bacillus anthracis. Infection and Immunity. 76: 899-906. PMID 18195035 DOI: 10.1128/Iai.01176-07  0.686
2007 Zhou Q, Gault RA, Kozel TR, Murphy WJ. Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells. Journal of Immunology (Baltimore, Md. : 1950). 178: 5753-61. PMID 17442959 DOI: 10.4049/Jimmunol.178.9.5753  0.334
2007 Kozel TR, Thorkildson P, Brandt S, Welch WH, Lovchik JA, AuCoin DP, Vilai J, Lyons CR. Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule. Infection and Immunity. 75: 152-63. PMID 17060470 DOI: 10.1128/Iai.01133-06  0.438
2006 Monari C, Kozel TR, Paganelli F, Pericolini E, Perito S, Bistoni F, Casadevall A, Vecchiarelli A. Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor. Journal of Immunology (Baltimore, Md. : 1950). 177: 6842-51. PMID 17082598 DOI: 10.4049/Jimmunol.177.10.6842  0.311
2006 Gates MA, Kozel TR. Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans. Infection and Immunity. 74: 3096-106. PMID 16714537 DOI: 10.1128/Iai.01213-05  0.342
2006 Lillegard JB, Sim RB, Thorkildson P, Gates MA, Kozel TR. Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo. The Journal of Infectious Diseases. 193: 1589-97. PMID 16652289 DOI: 10.1086/503804  0.671
2006 Zhou Q, Gault RA, Kozel TR, Murphy WJ. Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis. Infection and Immunity. 74: 2161-8. PMID 16552046 DOI: 10.1128/Iai.74.4.2161-2168.2006  0.316
2006 Zhang MX, Bohlman MC, Itatani C, Burton DR, Parren PW, St Jeor SC, Kozel TR. Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infection and Immunity. 74: 362-9. PMID 16368991 DOI: 10.1128/Iai.74.1.362-369.2006  0.431
2006 Chang ZL, Netski D, Thorkildson P, Kozel TR. Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages. Infection and Immunity. 74: 144-51. PMID 16368967 DOI: 10.1128/Iai.74.1.144-151.2006  0.329
2005 Monari C, Pericolini E, Bistoni G, Casadevall A, Kozel TR, Vecchiarelli A. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages. Journal of Immunology (Baltimore, Md. : 1950). 174: 3461-8. PMID 15749881 DOI: 10.4049/Jimmunol.174.6.3461  0.311
2005 Deyde V, Rizvanov A, Otteson E, Brandt S, Bego M, Pari G, Kozel T, St Jeor S. Identification of a monoclonal antibody from Peromyscus maniculatus (deer mouse) cytomegalovirus (PCMV) which binds to a protein with homology to the human CMV matrix protein HCMV pp71. Journal of Virological Methods. 123: 9-15. PMID 15582693 DOI: 10.1016/J.Jviromet.2004.08.024  0.409
2004 Kozel TR, Murphy WJ, Brandt S, Blazar BR, Lovchik JA, Thorkildson P, Percival A, Lyons CR. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proceedings of the National Academy of Sciences of the United States of America. 101: 5042-7. PMID 15051894 DOI: 10.1073/Pnas.0401351101  0.449
2004 Gates MA, Thorkildson P, Kozel TR. Molecular architecture of the Cryptococcus neoformans capsule. Molecular Microbiology. 52: 13-24. PMID 15049807 DOI: 10.1111/J.1365-2958.2003.03957.X  0.353
2004 Kozel TR, MacGill RS, Percival A, Zhou Q. Biological activities of naturally occurring antibodies reactive with Candida albicans mannan. Infection and Immunity. 72: 209-18. PMID 14688098 DOI: 10.1128/Iai.72.1.209-218.2004  0.468
2003 Brandt S, Thorkildson P, Kozel TR. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans. Clinical and Diagnostic Laboratory Immunology. 10: 903-9. PMID 12965925 DOI: 10.1128/Cdli.10.5.903-909.2003  0.44
2003 Kozel TR, Levitz SM, Dromer F, Gates MA, Thorkildson P, Janbon G. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infection and Immunity. 71: 2868-75. PMID 12704160 DOI: 10.1128/Iai.71.5.2868-2875.2003  0.346
2003 Monari C, Retini C, Casadevall A, Netski D, Bistoni F, Kozel TR, Vecchiarelli A. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. European Journal of Immunology. 33: 1041-51. PMID 12672070 DOI: 10.1002/Eji.200323388  0.375
2003 Duro RM, Netski D, Thorkildson P, Kozel TR. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan. Clinical and Diagnostic Laboratory Immunology. 10: 252-8. PMID 12626451 DOI: 10.1128/Cdli.10.2.252-258.2003  0.44
2002 Vecchiarelli A, Pietrella D, Bistoni F, Kozel TR, Casadevall A. Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells. Immunology. 106: 267-72. PMID 12047756 DOI: 10.1046/J.1365-2567.2002.01419.X  0.366
2002 Netski D, Kozel TR. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity. Infection and Immunity. 70: 2812-9. PMID 12010967 DOI: 10.1128/Iai.70.6.2812-2819.2002  0.415
2001 Zhang MX, Brandhorst TT, Kozel TR, Klein BS. Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast Infection and Immunity. 69: 7559-7564. PMID 11705933 DOI: 10.1128/Iai.69.12.7559-7564.2001  0.392
2001 Grinsell M, Weinhold LC, Cutler JE, Han Y, Kozel TR. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: A critical role for tissue macrophages Journal of Infectious Diseases. 184: 479-487. PMID 11471106 DOI: 10.1086/322787  0.337
2001 Han Y, Kozel TR, Zhang MX, MacGill RS, Carroll MC, Cutler JE. Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis Journal of Immunology. 167: 1550-1557. PMID 11466376 DOI: 10.4049/Jimmunol.167.3.1550  0.444
2001 MacGill TC, MacGill RS, Kozel TR. Capsular reactions of Cryptococcus neoformans with polyspecific and oligospecific polyclonal anticapsular antibodies Infection and Immunity. 69: 1189-1191. PMID 11160020 DOI: 10.1128/Iai.69.2.1189-1191.2001  0.41
2000 Feldmesser M, Rivera J, Kress Y, Kozel TR, Casadevall A. Antibody interactions with the capsule of Cryptococcus neoformans. Infection and Immunity. 68: 3642-50. PMID 10816523 DOI: 10.1128/Iai.68.6.3642-3650.2000  0.395
2000 MacGill TC, MacGill RS, Casadevall A, Kozel TR. Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans Journal of Immunology. 164: 4835-4842. PMID 10779792 DOI: 10.4049/Jimmunol.164.9.4835  0.34
1999 Pietrella D, Monari C, Retini C, Palazzetti B, Kozel TR, Vecchiarelli A. HIV type 1 envelope glycoprotein gp120 induces development of a T helper type 2 response to Cryptococcus neoformans Aids. 13: 2197-2207. PMID 10563705 DOI: 10.1097/00002030-199911120-00002  0.313
1999 Monari C, Kozel TR, Casadevall A, Pietrella D, Palazzetti B, Vecchiarelli A. B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans Immunology. 98: 27-35. PMID 10469230 DOI: 10.1046/J.1365-2567.1999.00853.X  0.327
1999 Syme RM, Bruno TF, Kozel TR, Mody CH. The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody Infection and Immunity. 67: 4620-4627. PMID 10456908 DOI: 10.1128/Iai.67.9.4620-4627.1999  0.433
1998 Zhang MX, Cutler JE, Han Y, Kozel TR. Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans Infection and Immunity. 66: 6027-6029. PMID 9826391 DOI: 10.1128/Iai.66.12.6027-6029.1998  0.413
1998 Mukherjee J, Kozel TR, Casadevaii A. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies Journal of Immunology. 161: 3557-3568. PMID 9759877  0.34
1998 Zhang MX, Kozel TR. Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway Infection and Immunity. 66: 4845-4850. PMID 9746588 DOI: 10.1128/Iai.66.10.4845-4850.1998  0.446
1998 Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrobial Agents and Chemotherapy. 42: 1437-46. PMID 9624491 DOI: 10.1128/Aac.42.6.1437  0.46
1998 Kozel TR, Macgill RS, Wall KK. Bivalency Is Required for Anticapsular Monoclonal Antibodies to Optimally Suppress Activation of the Alternative Complement Pathway by the Cryptococcus neoformans Capsule Infection and Immunity. 66: 1547-1553. PMID 9529080 DOI: 10.1128/Iai.66.4.1547-1553.1998  0.434
1998 Kozel TR, Dejong BCH, Grinsell MM, Macgill RS, Wall KK. Characterization of Anticapsular Monoclonal Antibodies That Regulate Activation of the Complement System by the Cryptococcus neoformans Capsule Infection and Immunity. 66: 1538-1546. PMID 9529079 DOI: 10.1128/Iai.66.4.1538-1546.1998  0.415
1998 Retini C, Vecchiarelli A, Monari C, Bistoni F, Kozel TR. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes Infection and Immunity. 66: 664-669. PMID 9453624 DOI: 10.1128/Iai.66.2.664-669.1998  0.351
1998 Vecchiarelli A, Retini C, Casadevall A, Monari C, Pietrella D, Kozel TR. Involvement of C3a and C5a in Interleukin-8 Secretion by Human Polymorphonuclear Cells in Response to Capsular Material of Cryptococcus neoformans Infection and Immunity. 66: 4324-4330. DOI: 10.1128/Iai.66.9.4324-4330.1998  0.37
1997 Zhang MX, Lupan DM, Kozel TR. Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans Infection and Immunity. 65: 3822-3827. PMID 9284158 DOI: 10.1128/Iai.65.9.3822-3827.1997  0.454
1997 Savoy AC, Lupan DM, Manalo PB, Roberts JS, Schlageter AM, Weinhold LC, Kozel TR. Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis Infection and Immunity. 65: 1800-1807. PMID 9125564 DOI: 10.1128/Iai.65.5.1800-1807.1997  0.344
1997 Belay T, Cherniak R, Kozel TR, Casadevall A. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay Infection and Immunity. 65: 718-728. PMID 9009335  0.354
1996 Belay T, Cherniak R, O'Neill EB, Kozel TR. Serotyping of Cryptococcus neoformans by dot enzyme assay Journal of Clinical Microbiology. 34: 466-470. PMID 8789042  0.323
1996 Kozel TR, Weinhold LC, Lupan DM. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans Infection and Immunity. 64: 3360-3368. PMID 8757876 DOI: 10.1128/Iai.64.8.3360-3368.1996  0.345
1996 Kozel TR, Tabuni A, Young BJ, Levitz SM. Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells Infection and Immunity. 64: 2336-2338. PMID 8675346 DOI: 10.1128/Iai.64.6.2336-2338.1996  0.338
1996 Kozel TR. Activation of the complement system by pathogenic fungi Clinical Microbiology Reviews. 9: 34-46. PMID 8665475 DOI: 10.1128/Cmr.9.1.34  0.372
1994 Keller RG, Pfrommer GST, Kozel TR. Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall Infection and Immunity. 62: 215-220. PMID 8262630  0.346
1994 Sahu A, Kozel TR, Pangburn MK. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation Biochemical Journal. 302: 429-436. PMID 8092994 DOI: 10.1042/Bj3020429  0.325
1994 Houpt DC, Pfrommer GS, Young BJ, Larson TA, Kozel TR. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infection and Immunity. 62: 2857-64. PMID 8005676  0.339
1993 Pfrommer GST, Dickens SM, Wilson MA, Young BJ, Kozel TR. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule Infection and Immunity. 61: 4360-4366. PMID 8406826 DOI: 10.1128/Iai.61.10.4360-4366.1993  0.319
1992 Kozel TR, Wilson MA, Welch WH. Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans. Infection and Immunity. 60: 3122-7. PMID 1639481 DOI: 10.1128/Iai.60.8.3122-3127.1992  0.304
1991 Kozel TR, Wilson MA, Murphy JW. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infection and Immunity. 59: 3101-10. PMID 1831795 DOI: 10.1128/Iai.59.9.3101-3110.1991  0.302
1990 Sanford JE, Lupan DM, Schlageter AM, Kozel TR. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide Infection and Immunity. 58: 1919-1923. PMID 2341184 DOI: 10.1128/Iai.58.6.1919-1923.1990  0.423
1990 Schlageter AM, Kozel TR. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide Infection and Immunity. 58: 1914-1918. PMID 2187813  0.34
1989 Kozel TR, Wilson MA, Farrell TP, Levitz SM. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae Infection and Immunity. 57: 3412-3417. PMID 2680973 DOI: 10.1128/Iai.57.11.3412-3417.1989  0.341
1989 Kozel TR, Wilson MA, Pfrommer GST, Schlageter AM. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins Infection and Immunity. 57: 1922-1927. PMID 2525113 DOI: 10.1128/Iai.57.7.1922-1927.1989  0.386
1989 Spiropulu C, Eppard RA, Otteson E, Kozel TR. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide Infection and Immunity. 57: 3240-3242. PMID 2476401  0.35
1988 Murphy JW, Mosley RL, Cherniak R, Reyes GH, Kozel TR, Reiss E. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infection and Immunity. 56: 424-31. PMID 3123390 DOI: 10.1128/Iai.56.2.424-431.1988  0.363
1988 Kozel TR, Pfrommer GS, Guerlain AS, Highison BA, Highison GJ. Role of the capsule in phagocytosis of Cryptococcus neoformans Reviews of Infectious Diseases. 10. PMID 3055212 DOI: 10.1093/Cid/10.Supplement_2.S436  0.377
1988 Kozel TR, Pfrommer GST, Guerlain AS, Highison BA, Highison GJ. Strain variation in phagocytosis of Cryptococcus neoformans: Dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3 Infection and Immunity. 56: 2794-2800. PMID 3049374 DOI: 10.1128/Iai.56.11.2794-2800.1988  0.349
1987 Eckert TF, Kozel TR. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide Infection and Immunity. 55: 1895-1899. PMID 2440810  0.361
1981 Kozel TR, Follette JL. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody Infection and Immunity. 31: 978-984. PMID 7014468 DOI: 10.1128/Iai.31.3.978-984.1981  0.407
1979 Kozel TR, McGaw TG. Opsonization of Cryptococcus neoformans by human immunoglobulin G: Role of immunoglobulin G in phagocytosis by macrophages Infection and Immunity. 25: 255-261. PMID 383614  0.314
1977 Kozel TR, Gulley WF, Cazin J. Immune response to Cryptococcus neoformans soluble polysaccharide: Immunological unresponsiveness Infection and Immunity. 18: 701-707. PMID 338489 DOI: 10.1128/Iai.18.3.701-707.1977  0.359
1976 Kozel TR, Mastroianni RP. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis Infection and Immunity. 14: 62-67. PMID 780279 DOI: 10.1128/Iai.14.1.62-67.1976  0.338
1974 Kozel TR, Cazin J. Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans Mycopathologia Et Mycologia Applicata. 54: 21-30. PMID 4139653 DOI: 10.1007/Bf02055969  0.414
1972 Kozel TR, Cazin J. Immune response to Cryptococcus neoformans soluble polysaccharide. I. Serological assay for antigen and antibody Infection and Immunity. 5: 35-41. PMID 4570986 DOI: 10.1128/Iai.5.1.35-41.1972  0.456
Show low-probability matches.